Colon tumors may be maintained by a rare fraction of cancer stem-like cells (CSC) that express the cell surface marker CD133. Self-renewing CSCs exhibit relatively greater resistance to clinical cytotoxic therapies and recent work suggests that this resistance may be mediated in part by an autocrine response to the immune cytokine interleukin 4 (IL-4). Blocking IL-4 signaling can sensitize CSCs to apoptotic stimuli and increase the in vivo efficacy of cytotoxic therapy. These findings suggest that inhibitors of IL-4 signaling may offer a new therapeutic tool in colon carcinoma
Francipane, M.G., Alea, M.P., Lombardo, Y., Todaro, M., Medema, J.P., Stassi, G. (2008). Crucial role of interleukin-4 in the survival of colon cancer stem cells. CANCER RESEARCH, 68(11), 4022-4025 [10.1158/0008-5472.CAN-07-6874].
Crucial role of interleukin-4 in the survival of colon cancer stem cells
TODARO, Matilde;STASSI, Giorgio
2008-01-01
Abstract
Colon tumors may be maintained by a rare fraction of cancer stem-like cells (CSC) that express the cell surface marker CD133. Self-renewing CSCs exhibit relatively greater resistance to clinical cytotoxic therapies and recent work suggests that this resistance may be mediated in part by an autocrine response to the immune cytokine interleukin 4 (IL-4). Blocking IL-4 signaling can sensitize CSCs to apoptotic stimuli and increase the in vivo efficacy of cytotoxic therapy. These findings suggest that inhibitors of IL-4 signaling may offer a new therapeutic tool in colon carcinoma
| File | Dimensione | Formato | |
|---|---|---|---|
|
4022.full.pdf
Solo gestori archvio
Dimensione
250.67 kB
Formato
Adobe PDF
|
250.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
